Kymera Therapeutics, Inc. — SC 13D/A Filings
5 SC 13D/A filings on record
This page lists all SC 13D/A filings submitted to the SEC by Kymera Therapeutics, Inc. (KYMR), sorted by most recent first. Each row links to the full filing on EdgarLookup. Kymera Therapeutics, Inc. has filed 5 SC 13D/A documents with the SEC since 2020. To view all SEC filings by Kymera Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
3
4
4/A
424B3
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DRS
EFFECT
S-1
S-1/A
S-1MEF
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13D/A | SC 13D/A | 0001104659-24-091998 | Aug 22, 2024 | — |
| SC 13D/A | AMENDMENT NO. 4 TO SCHEDULE 13D | 0000921895-24-000070 | Jan 9, 2024 | — |
| SC 13D/A | AMENDMENT NO. 3 TO THE SCHEDULE 13D | 0000921895-22-002521 | Aug 23, 2022 | — |
| SC 13D/A | AMENDMENT NO. 2 TO THE SCHEDULE 13D | 0000921895-22-001863 | Jun 1, 2022 | — |
| SC 13D/A | AMENDMENT NO. 1 TO THE SCHEDULE 13D | 0000921895-22-000281 | Jan 31, 2022 | — |